The results are from an early feasibility study (NCT05035823) investigating the technology in six patients with severe ...
Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...
More than one-third of adults in the United States have metabolic syndrome, a cluster of conditions that significantly raise ...
Despite recent advances in the treatment of breast cancer, it remains the second leading cause of cancer death in the U.S.
The trial's primary goal is to assess the efficacy, safety and tolerability of daily oral doses of SCI-110 in adults aged 18 ...